Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 2
2006 2
2007 2
2008 1
2009 2
2011 1
2012 1
2013 1
2014 1
2015 1
2016 2
2018 1
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Technologist Approach to Global Dose Optimization.
Costa PF, Testanera G, Camoni L, Terwinghe C, Bailey EA, Bolus NE, Alden TM; EANM Technologist Committee; on behalf of the ANZSNM Technologists Special Interest Group; on behalf of the SNMMI Technologist Section; CAMRT. Costa PF, et al. Among authors: terwinghe c. J Nucl Med Technol. 2019 Mar;47(1):75-82. doi: 10.2967/jnmt.118.218131. Epub 2018 Nov 9. J Nucl Med Technol. 2019. PMID: 30413598 Free article.
Best practice for the nuclear medicine technologist in CT-based attenuation correction and calcium score for nuclear cardiology.
Camoni L, Santos A, Attard M, Mada MO, Pietrzak AK, Rac S, Rep S, Terwinghe C, Fragoso Costa P; Technologist Committee of the European Association of Nuclear Medicine (EANM). Camoni L, et al. Among authors: terwinghe c. Eur J Hybrid Imaging. 2020 Jul 6;4(1):11. doi: 10.1186/s41824-020-00080-0. Eur J Hybrid Imaging. 2020. PMID: 34191150 Free PMC article. Review.
Dynamic 68Ga-DOTATOC PET/CT and static image in NET patients. Correlation of parameters during PRRT.
Van Binnebeek S, Koole M, Terwinghe C, Baete K, Vanbilloen B, Haustermans K, Clement PM, Bogaerts K, Verbruggen A, Nackaerts K, Van Cutsem E, Verslype C, Mottaghy FM, Deroose CM. Van Binnebeek S, et al. Among authors: terwinghe c. Nuklearmedizin. 2016 Jun 28;55(3):104-14. doi: 10.3413/Nukmed-0742-15-05. Epub 2016 Apr 8. Nuklearmedizin. 2016. PMID: 27056060
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Van Binnebeek S, Deroose CM, Baete K, Terwinghe C, Vanbilloen B, Koole M, Haustermans K, Mortelmans L, Verslype C, Van Cutsem E, Verbruggen A, Mottaghy FM. Van Binnebeek S, et al. Among authors: terwinghe c. J Clin Oncol. 2011 Jul 1;29(19):e579-81. doi: 10.1200/JCO.2010.34.3384. Epub 2011 May 9. J Clin Oncol. 2011. PMID: 21555687 No abstract available.
Synthesis of 18F-labelled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB.
Serdons K, Verduyckt T, Vanderghinste D, Cleynhens J, Borghgraef P, Vermaelen P, Terwinghe C, Van Leuven F, Van Laere K, Kung H, Bormans G, Verbruggen A. Serdons K, et al. Among authors: terwinghe c. Bioorg Med Chem Lett. 2009 Feb 1;19(3):602-5. doi: 10.1016/j.bmcl.2008.12.069. Epub 2008 Dec 24. Bioorg Med Chem Lett. 2009. PMID: 19147351
Significant impact of transient deterioration of renal function on dosimetry in PRRT.
Van Binnebeek S, Baete K, Terwinghe C, Vanbilloen B, Haustermans K, Mortelmans L, Borbath I, Van Cutsem E, Verslype C, Mottaghy FM, Verbruggen A, Deroose CM. Van Binnebeek S, et al. Among authors: terwinghe c. Ann Nucl Med. 2013 Jan;27(1):74-7. doi: 10.1007/s12149-012-0651-y. Epub 2012 Sep 9. Ann Nucl Med. 2013. PMID: 22961123
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
Van Binnebeek S, Vanbilloen B, Baete K, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Bogaerts K, Haustermans K, Nackaerts K, Van Cutsem E, Verslype C, Verbruggen A, Deroose CM. Van Binnebeek S, et al. Among authors: terwinghe c. Eur Radiol. 2016 Mar;26(3):900-9. doi: 10.1007/s00330-015-3882-1. Epub 2015 Jul 12. Eur Radiol. 2016. PMID: 26162577 Clinical Trial.
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
Van Binnebeek S, Baete K, Vanbilloen B, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Haustermans K, Van Cutsem E, Verbruggen A, Bogaerts K, Verslype C, Deroose CM. Van Binnebeek S, et al. Among authors: terwinghe c. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1141-57. doi: 10.1007/s00259-013-2670-x. Epub 2014 Mar 26. Eur J Nucl Med Mol Imaging. 2014. PMID: 24668274 Clinical Trial.
16 results